Arrhythmia Endpoints in Interventional Cardiovascular Trials: A Missed Opportunity?

Authors :: Bernard J. Gersh
Ori Ben-Yehuda
Ioanna Kosmidou
Shmuel Chen
Source :: Structural Heart. 3:20-23
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.
Abstract: Randomized clinical trials are the cornerstone of the collective process evaluating novel technologic and pharmacologic discoveries. The commercial availability of breakthrough therapies is conting...

Subjects :: medicine.medical_specialty
Randomized controlled trial
law
business.industry
medicine
Cardiology and Cardiovascular Medicine
Intensive care medicine
Missed opportunity
business
law.invention

Full Text Access

Tools